Your session is about to expire
← Back to Search
Genetic Testing Interventions for Cancer Risk (MiGHT Trial)
MiGHT Trial Summary
This trial is testing whether two experimental interventions (a website and motivational phone calls) increase the likelihood of patients getting genetic testing recommended by medical guidelines, compared to receiving usual care.
MiGHT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MiGHT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was diagnosed with prostate cancer before 50, am of Ashkenazi Jewish descent, or have a close relative with ovarian, pancreatic, breast (diagnosed before 50), or male breast cancer.I have a personal or family history of breast cancer with specific conditions.I have a history or risk of cancer based on family history or personal health.I meet the criteria for a genetic test due to certain conditions.I have had genetic testing for cancer or have an appointment for it.
- Group 1: Arm 1 - Usual care (UC)
- Group 2: Arm 2 - Virtual genetics navigator
- Group 3: Arm 3 - Motivational interviewing (MI)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current scale of enrolment for this research trial?
"Affirmative. The clinicaltrials.gov page contains information that this study has been enrolling patients since April 21st 2022, with the latest update happening on May 31st 2022. This trial is currently recruiting 759 participants from one medical centre."
Are participants being recruited for this experiment currently?
"Current information on clinicaltrials.gov affirms that this scientific trial is currently looking for participants, which it initially called for in April of 2022 and most recently updated at the end of May."
Share this study with friends
Copy Link
Messenger